文献速递脑血管病

加拿大年轻隐源性缺血性脑血管事件中法布里病患病率与结局

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.
PubMed 文献 · Stroke · 2017-06-08

本研究前瞻性纳入加拿大18至55岁隐源性缺血性卒中或短暂性脑缺血发作患者,进行α-半乳糖苷酶A基因测序以诊断法布里病,并评估卒中严重程度与功能结局。结果显示法布里病患病率极低(0.3%),年轻隐源性缺血性卒中整体功能结局良好,提示系统性基因筛查可能不具成本效益。

要点

  • 年轻隐源性缺血性卒中或TIA患者中法布里病患病率仅0.3%。
  • 6个月时87.4%患者改良Rankin量表评分为0至2分,结局良好。
  • 建议采用更具成本效益的方法诊断法布里病,而非系统基因筛查。

核心结论

  • 在加拿大年轻隐源性缺血性卒中或TIA患者中,法布里病患病率为0.3%(将p.R118C变异视为致病性时)。
  • 年轻成人隐源性缺血性卒中整体与良好功能结局相关。

研究设计与样本

  • 前瞻性队列研究,纳入年龄18至55岁、经预定检查未发现病因的缺血性卒中或言语/运动性TIA患者。
  • 共纳入365例缺血性卒中患者和32例TIA患者,进行α-半乳糖苷酶A基因测序。

主要发现

  • 基因测序仅发现1例意义未明变异(p.R118C)携带者,未发现公认的致病性变异。
  • 平均NIHSS评分为3.1;改良Rankin量表0至2分比例在≤7天为70.7%,6个月为87.4%。
  • 既往工作者中43%存在残余工作限制。

关键数值与推荐

  • 法布里病患病率0.3%(将p.R118C变异视为致病性时)。
  • 改良Rankin量表0至2分比例:≤7天70.7%,6个月87.4%。
  • 平均NIHSS评分3.1。
  • 98.7%患者返回家中;既往工作者中43%有残余工作限制。

临床怎么用

  • 在年轻隐源性缺血性卒中或TIA患者中,法布里病患病率极低,不建议进行系统性基因筛查。
  • 应考虑更具成本效益的诊断策略来识别法布里病。
  • 年轻隐源性缺血性卒中患者整体功能结局良好,但需关注残余工作限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Previous studies reported Fabry disease in 0% to 4% of young patients with cryptogenic ischemic stroke (IS). We sought to determine the prevalence of Fabry and outcomes among young Canadians with cryptogenic IS or transient ischemic attack (TIA). METHODS: We prospectively enrolled individuals aged 18 to 55 with IS or speech or motor TIA, and no cause identified despite predetermined investigation. α-galactosidase-A gene was sequenced for Fabry diagnosis. National Institutes of Health Stroke Scale score was measured at presentation to quantify stroke severity. Modified Rankin Scale determined functional outcomes ≤7 days after presentation and 6 months later. RESULTS: We enrolled 365 patients with IS and 32 with TIA. α-galactosidase-A sequencing identified a single carrier of a genetic variant of unknown significance (p.R118C) and no well-recognized pathogenic variants. Mean National Institutes of Health Stroke Scale score was 3.1. Proportion of patients with modified Rankin Scale of 0 to 2 was 70.7% at ≤7 days and 87.4% at 6 months. National Institutes of Health Stroke Scale score at presentation and diabetes mellitus predicted 6-month modified Rankin Scale. Thirteen patients experienced 5 recurrent IS and 9 TIA during follow-up. No patient died. Most patients (98.7%) returned home. Among previous workers, 43% had residual working limitations. CONCLUSIONS: In this Canadian cohort of patients with cryptogenic IS or TIA, the prevalence of Fabry was 0.3% if p.R118C variant is considered as pathogenic. This suggests that more cost-effective methods should be applied for diagnosis of Fabry rather than systematic genetic screening in this population. Overall, cryptogenic IS in young adults is associated with favorable outcomes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lanthier S, Saposnik G, Lebovic G, et al. Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events. Stroke. 2017. PMID: 28596458. doi:10.1161/STROKEAHA.116.016083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。